000 04040naa a22005057i 4500
001 UMUN-OA-20261005-MLS-065
003 local
005 20261005174906.0
006 m o d
007 cr||||||||||||
008 261005s2023 xx o u000 0 eng d
024 7 _a10.3390/antibiotics12111580
_2doi
035 _a(local)EuropePMC:PMC10668849
040 _alocal
_beng
_clocal
041 0 _aeng
100 0 _aIrene Bianconi
_eauthor.
245 1 0 _aCurrent Uses and Future Perspectives of Genomic Technologies in Clinical Microbiology. /
_cIrene Bianconi; Richard Aschbacher; Elisabetta Pagani.
264 1 _a[Place of publication not identified] :
_bMultidisciplinary Digital Publishing Institute (MDPI),
_c2023.
300 _a1 online resource (1 article).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aPublication type: Review article.
500 _aLinked open-access copy: published version.
506 0 _aOpen access; no subscription required for the linked open-access version.
_fUnrestricted online access
_2star
520 3 _aRecent advancements in sequencing technology and data analytics have led to a transformative era in pathogen detection and typing. These developments not only expedite the process, but also render it more cost-effective. Genomic analyses of infectious diseases are swiftly becoming the standard for pathogen analysis and control. Additionally, national surveillance systems can derive substantial benefits from genomic data, as they offer profound insights into pathogen epidemiology and the emergence of antimicrobial-resistant strains. Antimicrobial resistance (AMR) is a pressing global public health issue. While clinical laboratories have traditionally relied on culture-based antimicrobial susceptibility testing, the integration of genomic data into AMR analysis holds immense promise. Genomic-based AMR data can furnish swift, consistent, and highly accurate predictions of resistance phenotypes for specific strains or populations, all while contributing invaluable insights for surveillance. Moreover, genome sequencing assumes a pivotal role in the investigation of hospital outbreaks. It aids in the identification of infection sources, unveils genetic connections among isolates, and informs strategies for infection control. The One Health initiative, with its focus on the intricate interconnectedness of humans, animals, and the environment, seeks to develop comprehensive approaches for disease surveillance, control, and prevention. When integrated with epidemiological data from surveillance systems, genomic data can forecast the expansion of bacterial populations and species transmissions. Consequently, this provides profound insights into the evolution and genetic relationships of AMR in pathogens, hosts, and the environment.
540 _aCreative Commons Attribution. See the linked licence for the applicable terms.
_uhttps://creativecommons.org/licenses/by/4.0/
546 _aIn English.
588 0 _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source.
590 _aCourse allocation: B. Sc. Medical Laboratory Science.
650 4 _aGenome sequencing
650 4 _aAntimicrobial resistance
650 4 _aMetagenomics
650 4 _aMicrobial Genomics
653 _aB. Sc. Medical Laboratory Science
653 _aUMUN open access collection
653 _aclinical microbiology
655 4 _aReview articles.
700 0 _aRichard Aschbacher
_eauthor.
700 0 _aElisabetta Pagani
_eauthor.
773 0 _tAntibiotics (Basel, Switzerland)
_gVol. 12, no. 11, (2023), pages/article 1580
_x2079-6382
856 4 0 _uhttps://europepmc.org/articles/PMC10668849
_yRead open-access publication
_zOpen access.
_70
884 _aCourse selection and automated MARC21 enrichment from Europe PMC metadata.
_g20261005
_khttps://europepmc.org/articles/PMC10668849
_qlocal
942 _n0
999 _c1207
_d1207